In mice with bigger and more necrotic tumor masses, we observed a strong β2-AR cell membrane expression, which is strongly inhibited by the long-term treatment with the β2 selective antagonist ICI, and even more when in combination with CTX. The gene discussed is ADRB2; the disease is neoplasm.